Tokyo - Delayed Quote JPY
COSMOS Pharmaceutical Corporation (3349.T)
8,701.00
+47.00
+(0.54%)
At close: April 25 at 3:30:00 PM GMT+9
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Total Revenue
964,989,000
964,989,000
827,697,000
755,414,000
726,424,000
Cost of Revenue
776,683,000
776,683,000
658,979,000
603,966,000
581,313,000
Gross Profit
188,305,000
188,305,000
168,718,000
151,447,000
145,111,000
Operating Expense
156,804,000
156,804,000
138,589,000
121,651,000
111,964,000
Operating Income
31,501,000
31,501,000
30,129,000
29,796,000
33,147,000
Net Non Operating Interest Income Expense
-55,000
-55,000
-4,000
--
-3,000
Pretax Income
33,719,000
33,719,000
32,773,000
33,048,000
38,596,000
Tax Provision
9,265,000
9,265,000
8,975,000
9,892,000
11,439,000
Net Income Common Stockholders
24,454,000
24,454,000
23,797,000
23,155,000
27,156,000
Diluted NI Available to Com Stockholders
24,454,000
24,454,000
23,797,000
23,155,000
27,156,000
Basic EPS
308.61
--
300.48
292.38
342.90
Diluted EPS
308.61
--
300.48
292.38
342.90
Basic Average Shares
79,239.67
--
79,197.75
79,198.02
79,198.19
Diluted Average Shares
79,257.63
--
79,197.75
79,198.02
79,198.19
Total Operating Income as Reported
31,501,000
31,501,000
30,128,000
29,796,000
33,147,000
Total Expenses
933,487,000
933,487,000
797,568,000
725,617,000
693,277,000
Net Income from Continuing & Discontinued Operation
24,454,000
24,454,000
23,797,000
23,155,000
27,156,000
Normalized Income
24,873,907.65
24,873,907.65
24,022,831.57
23,023,973.25
25,248,480.39
Interest Income
44,000
44,000
47,000
52,000
57,000
Interest Expense
99,000
99,000
51,000
52,000
60,000
Net Interest Income
-55,000
-55,000
-4,000
--
-3,000
EBIT
33,818,000
33,818,000
32,824,000
33,100,000
38,656,000
EBITDA
53,742,000
53,742,000
50,192,000
48,210,000
52,441,000
Reconciled Cost of Revenue
776,683,000
776,683,000
658,979,000
603,966,000
581,313,000
Reconciled Depreciation
19,924,000
19,924,000
17,368,000
15,110,000
13,785,000
Net Income from Continuing Operation Net Minority Interest
24,454,000
24,454,000
23,797,000
23,155,000
27,156,000
Total Unusual Items Excluding Goodwill
-579,000
-579,000
-311,000
187,000
2,711,000
Total Unusual Items
-579,000
-579,000
-311,000
187,000
2,711,000
Normalized EBITDA
54,321,000
54,321,000
50,503,000
48,023,000
49,730,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-159,092.35
-159,092.35
-85,168.43
55,973.25
803,480.39
5/31/2021 - 11/11/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade